The Future of Patient-Derived Xenografts in Prostate Cancer Research

Although few prostate cancer patient-derived xenografts (PDXs) are available in large repositories, more PDXs are needed to reflect patient diversity, and to study new treatments and emerging mechanisms of resistance.
[Nature Reviews Urology]

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News